Literature DB >> 31981085

Gender Differences in the Pattern of Socio-Demographics Relevant to Metabolic Syndrome Among Kenyan Adults with Central Obesity at a Mission Hospital in Nairobi, Kenya.

Okubatsion Tekeste Okube1,2, Samuel T Kimani3, Waithira Mirie3.   

Abstract

INTRODUCTION: Metabolic syndrome (MetS) is a risk factor for cardiovascular-related morbidity and mortality. Although the risk factors for MetS are well documented, differences in gender-based demographics among Kenyan adults with central obesity are lacking. AIM: Determine gender differences in the pattern of socio-demographics relevant to metabolic syndrome among Kenyan adults with central obesity at a mission hospital, Nairobi.
METHODS: A cross-sectional baseline survey involving adults (N = 404) with central obesity aged 18-64 years, as part of a community-based lifestyle intervention study. Respondents were systematically sampled using the International Diabetes Federation definition for MetS. Lifestyle characteristics, anthropometric, clinical and biochemical markers were measured and analyzed using SPSS.
RESULTS: High (87.2%) MetS prevalence associated with advanced age in males (p < 0.001) and females (p = 0.002) was observed. MetS was likely among divorced/separated/widowed (p = 0.021) and high income males (p = 0.002) and females (p = 0.017) with high income. Unemployed males (p = 0.008) and females with tertiary education (p = 0.019) were less likely to have MetS. Advanced age was likely to lead to high blood pressure, fasting blood glucose and triglycerides (p < 0.05). Males were more likely (p = 0.026) to have raised triglycerides, while females (p < 0.001) had low high density lipoproteins.
CONCLUSION: A high prevalence of MetS associated with social and gender differences among Kenyan adults with central obesity. These underscore the need to look beyond the behavioral and biological risks and focus on every nuance of gender differences in addressing MetS and CVDs.

Entities:  

Keywords:  Anthropometric; Biomarkers; Gender difference; Kenya; Metabolic syndrome; Socio-demographic factors

Mesh:

Year:  2020        PMID: 31981085     DOI: 10.1007/s40292-020-00360-7

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  68 in total

1.  Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS).

Authors:  Takeki Suzuki; Kumiko Hirata; Mitchell S V Elkind; Zhezhen Jin; Tanja Rundek; Yumiko Miyake; Bernadette Boden-Albala; Marco R Di Tullio; Ralph Sacco; Shunichi Homma
Journal:  Am Heart J       Date:  2008-05-27       Impact factor: 4.749

2.  Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk.

Authors:  Jennifer L Kuk; Chris I Ardern
Journal:  Diabetes Care       Date:  2010-08-10       Impact factor: 17.152

Review 3.  Metabolic syndrome pandemic.

Authors:  Scott M Grundy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-03       Impact factor: 8.311

4.  All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.

Authors:  Athanase Benetos; Frédérique Thomas; Bruno Pannier; Kathy Bean; Bertrand Jégo; Louis Guize
Journal:  Am J Cardiol       Date:  2008-05-28       Impact factor: 2.778

5.  Prevalence of metabolic syndrome among an urban population in Kenya.

Authors:  Lydia U Kaduka; Yeri Kombe; Eucharia Kenya; Elizabeth Kuria; John K Bore; Zipporah N Bukania; Moses Mwangi
Journal:  Diabetes Care       Date:  2012-02-28       Impact factor: 19.112

6.  Controlling cardiovascular diseases in low and middle income countries by placing proof in pragmatism.

Authors:  Mayowa Owolabi; Jaime J Miranda; Joseph Yaria; Bruce Ovbiagele
Journal:  BMJ Glob Health       Date:  2016-10-05

7.  Association of lifestyle modification and pharmacological adherence on blood pressure control among patients with hypertension at Kenyatta National Hospital, Kenya: a cross-sectional study.

Authors:  Samuel Kimani; Waithira Mirie; Margaret Chege; Okubatsion Tekeste Okube; Samuel Muniu
Journal:  BMJ Open       Date:  2019-01-17       Impact factor: 2.692

8.  Sociodemographic disparities in the composition of metabolic syndrome components among adults in South Korea.

Authors:  Hyunjung Lim; Tuan Nguyen; Ryowon Choue; Youfa Wang
Journal:  Diabetes Care       Date:  2012-07-26       Impact factor: 19.112

9.  Impact of urbanization and gender on frequency of metabolic syndrome among native Abuja settlers in Nigeria.

Authors:  O Adediran; A A Akintunde; A E Edo; O G Opadijo; A M Araoye
Journal:  J Cardiovasc Dis Res       Date:  2012-07

Review 10.  Metabolic syndrome and incident diabetes: current state of the evidence.

Authors:  Earl S Ford; Chaoyang Li; Naveed Sattar
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 19.112

View more
  3 in total

1.  Egocentric social network characteristics and cardiovascular risk among patients with hypertension or diabetes in western Kenya: a cross-sectional analysis from the BIGPIC trial.

Authors:  Samuel G Ruchman; Allison K Delong; Jemima H Kamano; Gerald S Bloomfield; Stavroula A Chrysanthopoulou; Valentin Fuster; Carol R Horowitz; Peninah Kiptoo; Winnie Matelong; Richard Mugo; Violet Naanyu; Vitalis Orango; Sonak D Pastakia; Thomas W Valente; Joseph W Hogan; Rajesh Vedanthan
Journal:  BMJ Open       Date:  2021-09-02       Impact factor: 3.006

2.  Dietary Acid Load (DAL), Glycated Hemoglobin A1c (HbA1c), and Metabolic Syndrome (MeS) Mediate the Association of the Adherence to the Dietary Approaches to Stopping Hypertension (DASH) and Mediterranean Diet (MeD) With Nonalcoholic Fatty Liver Disease.

Authors:  Azam Doustmohammadian; Sakineh Nouri Saeidlou; Saeed Esfandyari; Esmaeel Gholizadeh; Mansooreh Maadi; Nima Motamed; Hossein Ajdarkosh; Mahmoodreza Khoonsari; Cain C T Clark; Farhad Zamani
Journal:  Front Nutr       Date:  2022-07-07

3.  Association of dietary patterns and practices on metabolic syndrome in adults with central obesity attending a mission hospital in Kenya: a cross-sectional study.

Authors:  Okubatsion Tekeste Okube; Samuel Kimani; Mirie Waithira
Journal:  BMJ Open       Date:  2020-10-12       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.